Chemical basis of ABO subgroups
Abstract
Despite the ABO histo-blood group system being the most biologically significant in
humans the chemical structures that define its various phenotypes still remain largely
unresolved. Like all blood group systems there is a significant range in the amount of
antigen present on the red cells of an individual and there exists a range of so-called
“weak” phenotypes represented by decreasing expression of A or B antigens. There
are a variety of known and speculative mechanisms that may result in these weaksubgroups/
phenotypes. Mechanisms resulting in weak-subgroups can include
glycosyltransferase catalytic domain mutations and mutations outside the catalytic
domain. Mechanisms resulting in weak-phenotypes can include insufficient
glycosyltransferase or precursor, secondary antigen acquisition, disruption in
biosynthesis, glycosyltransferase redundancy or degeneracy, antibody sensitivity and
specificity, chimera/transplantation/transfusion, infection, physiological changes and
finally artificial manipulation.
Weak-subgroups/phenotypes are potential windows into the biochemistry of the ABO
blood group system, due to the absence of dominating structures, and/or enhancement
of trace antigens caused by a loss in normal competition.
The aim of this thesis was to gain insights into chemical basis of the ABO system by
investigation of the mechanisms behind selected A weak-subgroups and/or A weakphenotypes.
A selected number of these were then biologically dissected and
immunochemically and structurally investigated in details. Structural analysis of
complex carbohydrate compounds is a delicate process where information from one
technique is compiled with information from other techniques to finally elucidate a
reliable identification of structure. It is the combination of analytical tools that allows
for robust interpretation of results that give insights to the biosynthetic and genetic
basis for the phenotypes.
In this thesis it was shown that the probable explanation between the A1 and the A2,
apart from the quantitative aspects, is that the A-type 4 structure seems to be missing
in the A2 phenotype. TLC investigations into a range of weak-subgroups revealed a
range of interesting anomalies, many of which have yet to be investigated.
Investigations on an individual A3 phenotype revealed an absence of branched
structures as a potential mechanism for the “mixed field” reaction. Also several new
structures including extended p-Fs (para-Forssman) structures were found. Finally the
Apae phenotype revealed an unexpectedly discovery that this phenotype is caused by
expression of the Forssman (Fs) antigen and not A antigens. This leads to a proposal to
establish the 31st blood group system, tentatively named FORS.
Although the contribution of glycoproteins and polyglycosylceramide to the
expression of weak ABO subgroups still remain uninvestigated the analysis of the
glycolipids alone has revealed a variety of significant insights into blood group A
subtypes/phenotypes.
Parts of work
I. Svensson L, Rydberg L, de Mattos L. C, Henry S. M (2009) Blood group A1 and A2 revisited: an immunochemical analysis. Vox Sang 96:56-61. ::PMID::19121199 II. Svensson L, Rydberg L, Hellberg Å, Gilliver L. G, Olsson M. L, Henry S.M (2005) Novel glycolipid variations revealed by monoclonal
antibody immunochemical analysis of weak ABO subgroups of A. Vox Sang 89:27-38.::PMID::15938737 III. Svensson L, Bindila L, Ångström J, Samuelsson B. E, Breimer M.E, Rydberg L, Henry S. M (2011) The structural basis of blood group A related glycolipids in an A3 red cell phenotype and a potential explanation to a serological phenomena. Glycobiology vol. 21 no. 2:162-
174.::PMID::20926599 IV. Svensson L, Hult A, Stamps R, Ångström J, Teneberg S, Storry J. R, Jørgensen R, Rydberg L, Henry S .M, Olsson M. L. Forssman
expression on human red blood cells – Biochemical and genetic evidence for a novel histo-blood group system with implications for
pathogen susceptibility. Manuscript
Degree
Doctor of Philosophy (Medicine)
University
University of Gothenburg. Sahlgrenska Academy
Institution
Institute of Biomedicine. Department of Clinical Chemistry and Transfusion Medicine
Disputation
Tisdagen den 15 november 2011, kl. 13.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3.
Date of defence
2011-11-15
lola.svensson@gu.se
Date
2011-10-28Author
Svensson, Lola
Keywords
ABO
subgroups
glycolipid
para-Forssman
Forssman
Forssman synthetase
Publication type
Doctoral thesis
ISBN
978-91-628-8346-1
Language
eng